demo, Author at News from the ECOG-ACRIN Cancer Research Group

Filter by
Categories
Tags
Authors
Show all

All
Adolescent and young adult oncology
Advanced practice providers
Advocacy
Artificial intelligence (AI)
Big data
Brain tumors
Breast cancer
Cancer care delivery research
Cancer control and survivorship
ComboMATCH precision medicine trial
Comis Symposium
Communication
Community oncology
Correlative science
COVID-19
Data science
Data security
Data stewardship
Federally-funded cancer research
Gastrointestinal cancers
Genitourinary cancers
Geriatric oncology
Group meeting
Head and neck cancer
Health equity
Imaging
Immunotherapy
In memory
Institution Evaluation
Leadership
Leukemia
Lung cancer
Lymphoma
Melanoma
Membership
Mentorship
Mesothelioma
Myelodysplastic syndromes
Myeloma
myeloMATCH
NCI
NCI-MATCH precision medicine trial
Patient-reported outcomes
Pragmatic clinical trials
Precision medicine
PrECOG
Prevention screening and surveillance
Public-private partnerships
Radiology
Real-world data
Research policy
Research results
Sarcoma
Social determinants of health
Symptom science and treatment toxicity
Targeted therapy
TMIST mammography trial
Tobacco cessation
Translational research

September 14, 2020

Trial Results: PALbociclib CoLlaborative Adjuvant Study (PALLAS)

A second interim analysis of this international adjuvant study for HR+, HER2- early breast cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence